Nicholas E. Johnson

3.5k total citations
101 papers, 1.8k citations indexed

About

Nicholas E. Johnson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Nicholas E. Johnson has authored 101 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cellular and Molecular Neuroscience, 54 papers in Molecular Biology and 35 papers in Neurology. Recurrent topics in Nicholas E. Johnson's work include Genetic Neurodegenerative Diseases (56 papers), Muscle Physiology and Disorders (32 papers) and Parkinson's Disease Mechanisms and Treatments (23 papers). Nicholas E. Johnson is often cited by papers focused on Genetic Neurodegenerative Diseases (56 papers), Muscle Physiology and Disorders (32 papers) and Parkinson's Disease Mechanisms and Treatments (23 papers). Nicholas E. Johnson collaborates with scholars based in United States, Canada and Italy. Nicholas E. Johnson's co-authors include Chad Heatwole, Michael McDermott, Nuran Dilek, Richard T. Moxley, William B. Martens, Rabi Tawil, Jeffrey Statland, Elizabeth Luebbe, Christine Quinn and Russell J. Butterfield and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Nicholas E. Johnson

92 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas E. Johnson United States	26	1.0k	953	612	285	188	101	1.8k
Chad Heatwole United States	27	1.1k 1.1×	1.1k 1.2×	627 1.0×	345 1.2×	215 1.1×	87	1.9k
William B. Martens United States	26	1.1k 1.0×	715 0.8×	467 0.8×	823 2.9×	128 0.7×	51	1.9k
Craig Campbell Canada	22	720 0.7×	338 0.4×	213 0.3×	236 0.8×	136 0.7×	90	1.3k
Rita Krishnamurthi New Zealand	7	1.3k 1.2×	524 0.5×	176 0.3×	348 1.2×	354 1.9×	13	1.8k
Rohit Bhattacharjee New Zealand	5	1.3k 1.2×	519 0.5×	160 0.3×	343 1.2×	340 1.8×	7	1.7k
Shivanthi Balalla New Zealand	6	1.3k 1.2×	516 0.5×	150 0.2×	344 1.2×	321 1.7×	6	1.7k
Matthew Pitt United Kingdom	23	481 0.5×	297 0.3×	596 1.0×	292 1.0×	135 0.7×	77	1.7k
Maja von der Hagen Germany	22	651 0.6×	249 0.3×	417 0.7×	196 0.7×	154 0.8×	80	1.5k
Sinéad M. Murphy Ireland	21	438 0.4×	1.1k 1.1×	506 0.8×	89 0.3×	93 0.5×	85	1.7k
Adnan Y. Manzur United Kingdom	26	1.5k 1.4×	351 0.4×	283 0.5×	535 1.9×	528 2.8×	63	2.1k

Countries citing papers authored by Nicholas E. Johnson

Since Specialization

Citations

This map shows the geographic impact of Nicholas E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas E. Johnson more than expected).

Fields of papers citing papers by Nicholas E. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas E. Johnson. The network helps show where Nicholas E. Johnson may publish in the future.

Co-authorship network of co-authors of Nicholas E. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas E. Johnson. A scholar is included among the top collaborators of Nicholas E. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas E. Johnson. Nicholas E. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Nicholas E., Jennifer Andrews, Yedatore Venkatesh, et al.. (2025). Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States. Neurology Genetics. 11(6). e200322–e200322.

Berggren, Kiera N., et al.. (2024). RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function. Annals of Clinical and Translational Neurology. 11(12). 3175–3191. 2 indexed citations

Trucco, Federica, Emilio Albamonte, Marika Pane, et al.. (2024). Parental diagnostic delay and developmental outcomes in congenital and childhood‐onset myotonic dystrophy type 1. Developmental Medicine & Child Neurology. 67(3). 365–373. 2 indexed citations

Alfano, Lindsay N., Jordi Díaz‐Manera, Linda Lowes, et al.. (2024). Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study. BMC Neurology. 24(1). 96–96.

Rosero, Spencer, et al.. (2023). The inclusion body myositis-health index (IBM-HI): Development and validation of a novel, disease-specific, patient-reported outcome measure. Journal of the Neurological Sciences. 455. 122033–122033.

Kang, Peter B., Suzanne McDermott, R. Stephen Berry, et al.. (2023). Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network. Neurology Genetics. 9(6). e200113–e200113. 3 indexed citations

Johnson, Nicholas E., et al.. (2023). An evaluation of the metabolic needs of people living with HIV/AIDS in Milton Keynes. Indian Journal of Sexually Transmitted Diseases and AIDS. 44(2). 179–182.

Butterfield, Russell J., Kristin M. Conway, Nicholas E. Johnson, et al.. (2022). Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non‐ambulatory males with Duchenne muscular dystrophy from MD STARnet. Muscle & Nerve. 66(1). 15–23. 6 indexed citations

Paramsothy, Pangaja, Kristin M. Conway, Nicholas E. Johnson, et al.. (2022). Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network. Neuromuscular Disorders. 32(6). 468–476. 8 indexed citations

10.

Mathews, Katherine D., Kristin M. Conway, Nicholas E. Johnson, et al.. (2021). Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Children. 8(10). 835–835. 4 indexed citations

11.

Conway, Kristin M., Katherine D. Mathews, Seth J. Perlman, et al.. (2021). A population‐based study of scoliosis among males diagnosed with a dystrophinopathy identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Muscle & Nerve. 65(2). 193–202. 3 indexed citations

12.

Wencel, Marie, Aziz Shaibani, Namita Goyal, et al.. (2021). Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices. Neurology Genetics. 7(6). e623–e623. 5 indexed citations

13.

Johnson, Nicholas E., Russell J. Butterfield, Katie Mayne, et al.. (2021). Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program. Neurology. 96(7). e1045–e1053. 85 indexed citations

14.

Pisciotta, Chiara, Emma Ciafaloni, Riccardo Zuccarino, et al.. (2020). Validation of the Italian version of the Charcot‐Marie‐Tooth Health Index. Journal of the Peripheral Nervous System. 25(3). 292–296. 3 indexed citations

15.

Pajusalu, Sander, Nicole J. Lake, Geyu Zhou, et al.. (2019). Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genetics in Medicine. 21(11). 2512–2520. 57 indexed citations

16.

Hung, Man, Jerry Bounsanga, Maren Wright Voss, et al.. (2018). Modified dynamic gait index and limits of stability in myotonic dystrophy type 1. Muscle & Nerve. 58(5). 694–699. 3 indexed citations

17.

Statland, Jeffrey, Anthony A. Amato, Elena Bravver, et al.. (2018). Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001). Neurology. 90(15_supplement). 4 indexed citations

18.

Johnson, Nicholas E., et al.. (2016). Management of Charcot–Marie–Tooth disease: improving long-term care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare. 9. 7–7. 33 indexed citations

19.

Tran, Cuc H., Joe Brew, Nicholas E. Johnson, et al.. (2016). Sustainability of school-located influenza vaccination programs in Florida. Vaccine. 34(24). 2737–2744. 9 indexed citations

20.

Johnson, Nicholas E., Chad Heatwole, Nuran Dilek, et al.. (2014). Quality-of-life in Charcot–Marie–Tooth disease: The patient’s perspective. Neuromuscular Disorders. 24(11). 1018–1023. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact